LA JOLLA, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LA JOLLA BIOENGINEERING INSTITUTE, founded in 2001, is a small nonprofit in the Science & Technology sector that reported $610K in total revenue in fiscal year 2018.
The Institute specializes in research on diseases whose origin and treatment are rooted in cell membrane mechanics. Such diseases include arteriosclerosis, osteoporosis, Alzheimer's and cardiovascular disease. Other biomechanical research includes anti-inflammatory biomaterials development and musculoskeletal properties research. The Institute receives substantially all of its revenue through grants from the National Institutes of Health.
La Jolla Bioengineering Institute (the Institute) was incorporated as a nonprofit public benefit corporation under the laws of California on December 19, 2001, and commenced operations in July 2002...
La Jolla Bioengineering Institute (the Institute) was incorporated as a nonprofit public benefit corporation under the laws of California on December 19, 2001, and commenced operations in July 2002. The Institute specializes in research on diseases whose origin and treatment are rooted in cell membrane mechanics. Such diseases include arteriosclerosis, osteoporosis, Alzheimer's and cardiovascular disease. Other biomechanical research includes anti-inflammatory biomaterials development and musculoskeletal properties research. The Institute receives substantially all of its revenue through grants from the National Institutes of Health.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2018 | 2017 | Change | |
|---|---|---|---|
| Revenue | $610,281 | $632,386 | 0.0% |
| Expenses | $606,527 | $633,271 | 0.0% |
| Net Income | $3,754 | $-885 | -5.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| FRANK PAPATHEOFANIS | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| MARCOS INTAGLIETTA | Chair | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MICHAEL NICOLAOU | Director/CFO | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| DOUGLAS STEWART | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| KONRAD MESSMER | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| JOHN A FRANGOS | President & CEO | 40.00 |
Officer
|
$246,650 | $68,994 | $315,644 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2019 | $610,281 | $606,527 | $262,537 | $3,754 |
Compare LA JOLLA BIOENGINEERING INSTITUTE with other nonprofits in California and across the country.